Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:BHF
NasdaqGS:BHFInsurance

Brighthouse Financial (BHF) Q1 Loss Of US$792m Tests Bullish Profitability Narratives

Brighthouse Financial (BHF) opened 2026 with Q1 revenue of US$1.5b and a basic EPS loss of US$13.72, alongside net income excluding extra items of a US$792m loss. On a trailing 12 month basis, revenue stood at US$6.1b with a basic EPS loss of US$2.92 and a US$167m net loss. Over recent quarters the company has seen revenue move from US$2.4b in Q1 2025 to US$1.9b in Q4 2025 and US$1.5b in Q1 2026. Basic EPS has ranged from a loss of US$5.05 in Q1 2025 to a profit of US$10.80 in Q4 2024 before...
NasdaqGS:ATNI
NasdaqGS:ATNITelecom

ATN International (ATNI) EPS Loss Persists And Tests Bullish Profit-Recovery Narrative

ATN International (ATNI) opened 2026 with Q1 revenue of US$182.2 million and a basic EPS loss of US$0.18, while trailing 12 month revenue stood at US$730.9 million against a net loss of US$14.9 million. Over recent quarters, revenue has moved in a tight band between US$179.3 million and US$184.2 million. During the same period, basic EPS has swung from a profit of US$0.18 in Q3 2025 to losses of US$0.56 in Q2 2025 and US$0.32 in Q4 2025. This sets up a quarter where investors are focused less...
NYSE:MTB
NYSE:MTBBanks

M&T Bank Weighs In Footprint Deals To Deepen Regional Strength

M&T Bank is actively assessing targeted acquisitions within its 13 state footprint to increase regional scale. The company is focusing on adding density in existing markets rather than pursuing a national expansion strategy. This comes as regulators appear more open to bank mergers, creating a more supportive backdrop for deals. M&T Bank (NYSE:MTB) is sharpening its focus on regional growth, with management exploring acquisitions that fit within its existing footprint instead of chasing...
NasdaqCM:NVEC
NasdaqCM:NVECSemiconductor

NVE (NVEC) Net Margin Near 58% Tests Bearish Profitability Narratives

FY 2026 earnings snapshot and how the stories stack up NVE (NVEC) has just wrapped up FY 2026 with fourth quarter revenue of US$7.7 million and basic EPS of US$1.02, set against trailing twelve month revenue of US$26.3 million and EPS of US$3.14 as the stock trades at US$88.59. Over recent quarters the company has seen revenue range from US$6.1 million to US$7.7 million and quarterly EPS move between US$0.68 and US$1.02. This gives investors a clearer read on how the topline and per share...
TSX:KXS
TSX:KXSSoftware

Kinaxis (TSX:KXS) Net Margin Jump Reinforces Bullish AI Earnings Narrative

Kinaxis (TSX:KXS) opened 2026 with Q1 revenue of US$165.6 million and basic EPS of US$1.06, setting the tone for how the rest of the year could shape up for earnings focused investors. Over recent quarters the company has seen revenue move from US$132.8 million in Q1 2025 to US$144.2 million in Q4 2025 and then to US$165.6 million in Q1 2026, while quarterly basic EPS over the same stretch went from US$0.57 to US$0.70 and then to US$1.06. This has put the spotlight firmly on how sustainable...
NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

Mirum Pharmaceuticals (MIRM) Posts Huge US$790 Million Loss Challenging Bullish Profitability Narrative

Mirum Pharmaceuticals (MIRM) just posted Q1 2026 results with revenue of US$159.9 million, a basic EPS loss of US$13.43 and net income loss excluding extra items of US$790.2 million. The company has reported quarterly revenue of US$99.4 million in Q4 2024, US$111.6 million in Q1 2025, US$127.8 million in Q2 2025, US$133.0 million in Q3 2025 and US$148.9 million in Q4 2025, while EPS over those periods ranged between a loss of US$0.50 and a profit of US$0.06. For investors, a key focus this...
NasdaqGS:ROIV
NasdaqGS:ROIVBiotechs

Baron Fund Puts Spotlight On Roivant’s Brepocitinib And Valuation Gap

Baron Health Care Fund recently highlighted Roivant Sciences (NasdaqGS:ROIV) for positive Phase 2 results of brepocitinib in cutaneous sarcoidosis. The fund called brepocitinib's data a potential major catalyst and suggested the market may be underestimating the drug's franchise value. This public endorsement draws fresh attention to Roivant's pipeline beyond earlier discussions about its valuation or analyst coverage. Roivant Sciences focuses on developing and commercializing therapies...
NYSE:CMG
NYSE:CMGHospitality

Is Chipotle Mexican Grill (CMG) Attractive After A 35% One-Year Share Price Slide?

Curious whether Chipotle Mexican Grill at around US$33.27 is a bargain or still priced for perfection? This breakdown will help you put the current stock price into context. Over the last week the stock posted a 2.1% decline, and over the past year it has returned a 35.3% decline, which may have some investors questioning whether sentiment has shifted or if there is a potential opening. Recent coverage has focused on Chipotle's position as a major US fast-casual restaurant chain and how its...
NYSE:MDU
NYSE:MDUGas Utilities

MDU Resources Group (MDU) Q1 Margin Stability Tests Bullish Earnings Growth Narrative

MDU Resources Group (MDU) opened 2026 with Q1 revenue of $606 million and basic EPS of $0.39, while trailing 12 month revenue stood at about $1.8 billion and EPS at $0.93. This sets a clear baseline for how the business is currently earning its way. The company has seen quarterly revenue shift from $674.8 million in Q1 2025 to $606 million in Q1 2026, with basic EPS moving from $0.40 to $0.39 over the same period. This gives investors a straightforward read on how recent trading compares with...
NasdaqGS:GERN
NasdaqGS:GERNBiotechs

Can Geron’s (GERN) Narrowing Losses Reframe Expectations For Its Blood Cancer Earnings Potential?

Geron Corporation has already reported first-quarter 2026 results, with revenue rising to US$51.84 million from US$39.6 million and net loss narrowing to US$3.64 million from US$19.84 million a year earlier, while also outlining upcoming May investor conference presentations on its blood cancer programs. The sharp reduction in quarterly net loss and loss per share, achieved alongside higher revenue, highlights how Geron’s commercial ramp is affecting its income statement. We’ll now examine...
HLSE:SANOMA
HLSE:SANOMAMedia

Sanoma Oyj (HLSE:SANOMA) Q1 Loss Tests Bullish Margin Recovery Narrative

Sanoma Oyj (HLSE:SANOMA) opened 2026 with Q1 revenue of €225.8 million and a basic EPS loss of €0.16, while trailing twelve month EPS stood at €0.09 on revenue of about €1.3 billion and net income of €14.9 million. Over recent quarters the company has seen revenue move from €221.1 million and EPS of a €0.19 loss in Q1 2025 to €339.8 million and €0.19 EPS in Q2 2025, €515.8 million and €0.34 EPS in Q3 2025, and €225.8 million with a €0.27 loss per share in Q4 2025. This sets up Q1 2026 against...
NYSE:LNC
NYSE:LNCInsurance

Lincoln National (LNC) Q1 Loss Tests Bullish Margin Improvement Narrative

Lincoln National (LNC) kicked off Q1 2026 with revenue of US$5.3 billion and a basic EPS loss of US$1.10, as net income excluding extra items came in at a loss of US$201 million against a growing trailing twelve month earnings base. Over the last year, the company has seen trailing twelve month revenue move from US$18.0 billion to US$18.9 billion, while trailing basic EPS shifted from US$6.06 to US$8.69 and net income excluding extra items moved from US$1.0 billion to US$1.6 billion. In this...
NasdaqGS:ECPG
NasdaqGS:ECPGConsumer Finance

Encore Capital Group (ECPG) Profitability Return Tests Bearish Narratives In Q1 2026

Encore Capital Group (ECPG) opened Q1 2026 with total revenue of US$475.4 million and basic EPS of US$3.97, while trailing 12 month EPS sat at US$13.05 on revenue of US$1.9 billion. This provides a clear snapshot of both the latest quarter and the broader run rate. Over the past five quarters, the company has seen revenue move from US$265.6 million in Q4 2024 to US$392.8 million in Q1 2025 and then to US$475.4 million in Q1 2026. Quarterly basic EPS shifted from a loss of US$9.42 in Q4 2024...
NasdaqCM:CELH
NasdaqCM:CELHBeverage

Celsius Holdings (CELH) Margin Compression To 3.9% Tests Bullish Growth Narratives

Celsius Holdings (CELH) has put up a busy start to 2026, reporting Q1 revenue of US$782.6 million and basic EPS of US$0.33, alongside trailing twelve month revenue of US$3.0 billion and EPS of US$0.44. Over recent quarters the company has seen revenue move from US$332.2 million in Q4 2024 to between roughly US$329.3 million and US$739.3 million through 2025, while EPS has ranged from a loss of US$0.27 per share in Q3 2025 to US$0.35 per share in Q2 2025. With trailing net profit margins at...
NasdaqCM:PGY
NasdaqCM:PGYSoftware

Pagaya Technologies (PGY) Profit Run Rate Challenges Earnings Quality Skepticism

Pagaya Technologies (PGY) opened Q1 2026 with revenue of US$317.9 million and basic EPS of US$0.30, setting a clear marker for how its earnings engine is running right now. The company reported revenue of US$289.9 million and EPS of US$0.10 in Q1 2025 and US$334.8 million and EPS of US$0.40 in Q4 2025. This gives a clear view of how the top and bottom line have tracked into the current quarter, while net income of US$24.7 million keeps the focus firmly on margins. See our full analysis for...
NYSE:AGL
NYSE:AGLHealthcare

Agilon Health (AGL) Swings To Q1 Profit Challenging Longstanding Loss-Making Narrative

agilon health (AGL) opened 2026 with Q1 revenue of US$1.4b and basic EPS of US$1.80, alongside net income from continuing operations of about US$10.9m and earnings from discontinued operations of US$19m. The company has seen quarterly revenue fluctuate around the US$1.4b to US$1.6b range since early 2024, while trailing 12 month EPS sits at a loss of US$22.53 on net income from continuing operations of US$373.5m. This puts the spotlight firmly on how sustainably these latest margins have been...
SEHK:2618
SEHK:2618Logistics

JD Logistics (SEHK:2618) Valuation Check As New UAE ROX Warehouse Expands MENA Logistics Reach

Why JD Logistics stock is back on investors’ radar JD Logistics (SEHK:2618) has drawn fresh attention after partner ROX announced a new 1,000 sqm regional spare parts warehouse in the UAE, using JD Logistics infrastructure to support after-sales service across the wider MENA region. See our latest analysis for JD Logistics. Beyond the ROX partnership, JD Logistics has attracted interest as the share price climbed to HK$15.09, with a 30 day share price return of 6.87% and a 90 day share price...
NasdaqGM:VNDA
NasdaqGM:VNDABiotechs

Vanda Pharmaceuticals (VNDA) Losses Deepen To US$239.5 Million LTM Reinforcing Bearish Narratives

Vanda Pharmaceuticals (VNDA) opened Q1 2026 with total revenue of US$51.7 million and a basic EPS loss of US$0.82, while the trailing twelve months show revenue of US$217.8 million and a basic EPS loss of US$4.05. Over recent quarters the company has seen revenue move in a tight band between US$50.0 million and US$57.2 million and quarterly basic EPS losses range from US$0.08 to US$2.39. The latest figures fit into a pattern of steady sales alongside widening losses at the bottom line. For...
OTCPK:FMCC
OTCPK:FMCCDiversified Financial

Is It Time To Reconsider Federal Home Loan Mortgage (OTCPK:FMCC) After Recent Share Price Swings

Wondering if Federal Home Loan Mortgage at around US$7.14 is a bargain or already pricing in the key positives? This article breaks down what the current price might be implying about the stock. The stock has returned 0.6% over the last week and 26.4% over the past month, while the year-to-date return is a 31.0% decline and the 1-year return sits at 31.7%. Over the past 3 years the share price move has been very large relative to the starting point, and the 5-year return of 243.3% means...
NYSE:WTRG
NYSE:WTRGWater Utilities

Essential Utilities (WTRG) Margin Compression Tests Bullish Earnings Growth Narrative

Essential Utilities (WTRG) opened 2026 with Q1 revenue of US$861.8 million and basic EPS of US$0.79, against a backdrop where trailing 12 month revenue stood at about US$2.6 billion and EPS was US$1.97, alongside a clear step down in earnings over the most recent year. The company has seen quarterly revenue move from US$783.6 million in Q1 2025 to US$861.8 million in Q1 2026, while basic EPS shifted from US$1.03 to US$0.79 over the same period, presenting a picture in which investors are...
NasdaqGM:PDYN
NasdaqGM:PDYNMachinery

Palladyne AI (PDYN) Valuation After Reaffirmed 2026 Guidance And First Quarter 2026 Results

Why Palladyne AI stock is back in focus Palladyne AI (PDYN) has drawn fresh attention after reaffirming its 2026 revenue outlook of US$24 million to US$27 million and reporting first quarter 2026 results, including sales of US$3.54 million and a net loss of US$12.61 million. See our latest analysis for Palladyne AI. The reaffirmed 2026 guidance and first quarter revenue update come after a mixed price pattern, with a 1-day share price return of 4.8% decline, a 90-day share price return of...
SASE:8250
SASE:8250Insurance

Exploring Three Undiscovered Gem Stocks In The Middle East

The Middle East stock markets have recently experienced positive momentum, buoyed by robust corporate earnings and optimism surrounding a potential U.S.-Iran peace deal. As Gulf markets gain ground, investors are increasingly eyeing smaller companies that may offer unique growth opportunities in this dynamic region. In such an environment, identifying promising stocks involves looking for strong financial performance and strategic positioning within key sectors.